Zandra K Klippel

Suggest Changes
  • Citations Per Year
Learn More
BACKGROUND Pegfilgrastim's role in reducing the risk of febrile neutropenia (FN) in patients with colorectal cancer (CRC) receiving chemotherapy plus bevacizumab was not previously evaluated in a(More)
INTRODUCTION High-dose melphalan and autologous stem cell transplantation (HDM/SCT) is an effective treatment modality for immunoglobulin light-chain (AL) amyloidosis; however, its application(More)
BACKGROUND Mild-to-moderate bone pain is the most commonly reported adverse event associated with pegfilgrastim. AIMS To investigate the effect of bone pain education on pegfilgrastim-related bone(More)